SKB264

Clinical trials for SKB264 explained in plain language.

Never miss a new study

Get alerted when new SKB264 trials appear

Sign up with your email to follow new studies for SKB264, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for breast cancer patients who stopped responding to standard therapy

Disease control Recruiting now

This phase 2 trial tests a combination of two drugs, SKB264 and inetetamab, in 48 adults with HER2-positive advanced breast cancer that has worsened after prior treatment with T-DXd. The goal is to see if the combo can shrink tumors. Participants receive the drugs intravenously e…

Matched conditions: SKB264

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Jul 17, 2026 00:00 UTC

SKB264

Get alerted when new SKB264 trials appear

New hope for breast cancer patients who stopped responding to standard therapy